Phase II Trial of Thalidomide (Thalidomide Pharmion) in Patients With Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT).

Trial Profile

Phase II Trial of Thalidomide (Thalidomide Pharmion) in Patients With Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT).

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2009

At a glance

  • Drugs Thalidomide (Primary)
  • Indications MALT lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2009 Actual patient number (8) added as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top